Dexmedetomidine alleviates hippocampal neuronal damage in epilepsy through BDNF/TrkB pathway by inhibiting MeCP2. (2024). Indian Journal of Biochemistry and Biophysics (IJBB), 61(4), 241-251. https://doi.org/10.56042/ijbb.v61i4.8422